Gene · 8000
Papers1,687
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,687
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Vaccines as treatments for prostate cancer. | Nat Rev Urol | 2023 | 36879114 | PubTator, text mining | PubMed |
| Anti-ROR1 CAR-T cells: Architecture and performance. | Front Med (Lausanne) | 2023 | 36873868 | PubTator, text mining | PubMed |
| The PSCA rs2294008 (C/T) Polymorphism Increases the Risk of Gastric and Bladder Cancer: A Meta-Analysis. | Genet Test Mol Biomarkers | 2023 | 36853840 | PubTator, text mining | PubMed |
| mRNA-Based Therapeutics in Cancer Treatment. | Pharmaceutics | 2023 | 36839944 | PubTator, text mining | PubMed |
| Nanomedicine for Combination Urologic Cancer Immunotherapy. | Pharmaceutics | 2023 | 36839868 | PubTator, text mining | PubMed |
| Microwave-Assisted Functionalization of Multi-Walled Carbon Nanotubes for Biosensor and Drug Delivery Applications. | Pharmaceutics | 2023 | 36839659 | PubTator, text mining | PubMed |
| Nanoparticle-Based Techniques for Bladder Cancer Imaging: A Review. | Int J Mol Sci | 2023 | 36835222 | PubTator, text mining | PubMed |
| CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy. | Cancers (Basel) | 2023 | 36831396 | PubTator, text mining | PubMed |
| The Current Progress and Future Options of Multiple Therapy and Potential Biomarkers for Muscle-Invasive Bladder Cancer. | Biomedicines | 2023 | 36831075 | PubTator, text mining | PubMed |
| mRNA-From COVID-19 Treatment to Cancer Immunotherapy. | Biomedicines | 2023 | 36830845 | PubTator, text mining | PubMed |
| CAR Based Immunotherapy of Solid Tumours-A Clinically Based Review of Target Antigens. | Biology (Basel) | 2023 | 36829563 | PubTator, text mining | PubMed |
| Palbociclib impairs the proliferative capacity of activated T cells while retaining their cytotoxic efficacy. | Front Pharmacol | 2023 | 36817127 | PubTator, text mining | PubMed |
| Immunotherapy in breast cancer: an overview of current strategies and perspectives. | NPJ Breast Cancer | 2023 | 36781869 | PubTator, text mining | PubMed |
| T lymphocyte cell: A pivotal player in lung cancer. | Front Immunol | 2023 | 36776832 | PubTator, text mining | PubMed |
| Molecular Pathways of Diabetic Kidney Disease Inferred from Proteomics. | Diabetes Metab Syndr Obes | 2023 | 36760602 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors: The Past and the Future. | J Immunother Precis Oncol | 2023 | 36751657 | PubTator, text mining | PubMed |
| Energetic Diversity in the Electron-Transfer Pathways of Type I Photosynthetic Reaction Centers. | Biochemistry | 2023 | 36749324 | PubTator, text mining | PubMed |
| Integrated multi-dimensional analysis highlights DHCR7 mutations involving in cholesterol biosynthesis and contributing therapy of gastric cancer. | J Exp Clin Cancer Res | 2023 | 36710342 | PubTator, text mining | PubMed |
| Diagnostic Efficacy of PSMA and PSCA mRNAs Combined to PSA in Prostate Cancer Patients. | Asian Pac J Cancer Prev | 2023 | 36708571 | PubTator, text mining | PubMed |
| Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment. | Exp Hematol Oncol | 2023 | 36707873 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8000/papers?page=12